Soley Therapeutics
PrivateLast Round
Series C
Jan 7, 2026
Total Funding Raised
$290M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Soley Therapeutics is a biotechnology company that uses its proprietary cell stress-sensing platform, integrated with AI and automation, to discover and develop first-in-class medicines for oncology, neurodegenerative, and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Soley Therapeutics Comparables
Compare Soley Therapeutics with similar companies based on industry and business-model similarity.
Soley Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 7, 2026 | ||||
| Series A | Dec 22, 2020 |
Key People
Founding team and executive leadership
Soley Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series C |
| Breyer Capital | Series B, Series C, Series A |
| GordonMD Global Investments | Series B, Series C, Series A |
| HRTG Partners | Series C |
| RWN Management | Series C |
| Citadel | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Preclinical data for STX-6398 presented at AACR Annual Meeting 2026.
- Mar 18, 2026
STX-6398 targets undruggable CKAP2 for selective anti-tumor activity.
Soley Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Soley Therapeutics's valuation, stock price, and market status.